Custom EarPeace x NPR Music to Include the Patented Music PRO 20dB Model that Elevates the Sound Experience While Reducing Harmful Decibels Levels

EarPeace are among the best earplugs out there and have used them literally at over a thousand shows. My ears thank you. -Bob Boilen, Creator/Host of All Songs Considered and Tiny Desk Concerts.

WASHINGTON (PRWEB)
February 16, 2022

Today, EarPeace announced they are collaborating with NPR to create a line of custom branded earplugs in order to reduce noise-induced hearing loss (NIHL) amongst artists and music fans.

For the collaboration, NPR x EarPeace will include the newly patented EarPeace PRO earplugs. EarPeace PRO features a contoured design that conforms to the natural shape of the ear canal. Combined with the finely tuned acoustic mesh filter that precisely replicates the sound signature, PRO delivers a true-to-life audio experience at a safe volume for discerning artists and music fans.

“I am a native Washingtonian and die-hard NPR fan. Chances are 50/50 whether I’m listening to music or the dulcet tones of NPR news keeping me informed. Working with NPR to keep the community’s hearing healthy is a profound honor,” said Jay Clark, Founder and CEO of EarPeace. “When I first launched EarPeace, one of the first people I approached to test drive the plugs was NPR Music’s Bob Boilen. If anyone knows live shows and the subtlety of music, it’s Bob.”

“EarPeace are among the best earplugs out there and have used them literally at over a thousand shows. My ears thank you,” stated Bob Boilen, Creator/Host of All Songs Considered and Tiny Desk Concerts.

According to the Centers for Disease Control and Prevention (CDC), in less than five minutes at a rock concert, NIHL has already begun. In the past year, roughly 25 million Americans have experienced tinnitus. As a result, hearing loss remains the third most common chronic physical condition in the United States and is twice as prevalent as diabetes or cancer.*

“Unless I’m mixing and recording at the Tiny Desk, I’m using hearing protection at concerts. EarPeace has been one of my go-to brands for years. Do your future self a favor and protect your ears,” said Josh Rogosin, Tiny Desk Audio Engineer and Technical Director for NPR Music, who, even prior to the collaboration with EarPeace, has been an advocate for safe listening with hearing protection.

Recently granted their second patent for the proprietary design of their earplugs following their utility patent, PRO resolves a common problem in traditional earplugs that contain rigid components by eliminating the mismatch between the shape of the ear and plug. The earplugs use less material to optimally expand in the ear canal, minimizing unwanted bunching and slit leaks. In addition to the higher level of comfort, the oval, offset wave shape of their patented design permits the filters to perform at peak capacity.

On a mission to save the world’s hearing and prevent NIHL, EarPeace hasn’t stopped at revolutionizing hearing protection options – they continue to lead the charge in how people value their hearing health as well as efforts to reduce the epidemic of hearing loss and tinnitus. EarPeace is trusted by NPR, Metallica, RedBull, Lollapalooza, and more.

For more information on the EarPeace, please visit: https://www.earpeace.com.

###

About EarPeace:

EarPeace revolutionized hearing protection in 2008 with a discreet, comfortable, high-fidelity earplug built not only for musicians, but for all the fans at the event. This same technology was customized for motorsports, travel, anyone that needs a safety product, and for everyone that needs a good night’s sleep. The innovation by EarPeace continues today with new patents, products, technologies, and accessories designed to “enhance your experience.” Festivals, motorcycle rallies, and events all over the world depend on EarPeace to keep their stars and fans safe, comfortable, and ready for the next event. EarPeace’s promise is simple – you will hear and feel better when you wear EarPeace. For more information, visit: https://www.earpeace.com.

*Based on calculations performed by NIDCD Epidemiology and Statistics Program staff: (1) tinnitus prevalence was obtained from the 2008 National Health Interview Survey (NHIS); (2) the estimated number of American adults reporting tinnitus was calculated by multiplying the prevalence of tinnitus by the 2013 U.S. Census population estimate for the number of adults (18+ years of age)(Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for US adults: National Health Interview Survey, 2012. Vital Health Stat 10. 2014;260:1-161.)

Share article on social media or email:

“We are pleased that Health Canada has recognized psilocybin as a possible remedy for unmet mental conditions and we are proud to be part of its development”

HAWKESBURY PROVIDENCE, Ontario (PRWEB)
February 16, 2022

Zollaris Laboratories Corporation. (hereafter, “Zollaris”) receives authorization from the Health Canada, Office of Controlled Substances for analytical investigation of several psilocybin powders currently permitted under license and available in Canada. The Health Canada license permits Zollaris to proceed to screen suitable candidates and drug preparations to be used in clinical trials to be initiated in 2022. Health Canada has recognized the importance of Zollaris’ analytical research infrastructure, drug development and manufacturing programs aimed at producing a molecular standardization of psilocybin form factors.

Psilocybin therapy is an approach being investigated for the treatment of mental health challenges where current drug therapies have known and unwanted adverse effects and present high potential to addiction. Psilocybin is a psychoactive ingredient found in some species of mushrooms, often referred to as ”magic mushrooms” and which have been the focus of renewed interest for medical use in mental health where current therapeutics are not ideal. With this license, Zollaris can enter the pharmaceutical drug development arena to develop future therapeutics.

Under the title of “Drug Development Pathways to Bring Psilocybin (and Psilocin) to the Pharmaceutical Market”, Zollaris Labs will complete the necessary steps in order to produce the first standard of Psilocybin to be sold under USP certification.

Zollaris investigational program is a pivotal passage to get pharmaceutical grade Psilocybin powders with a Made in Canada stamp, in our fully licensed GMP Facility.

ABOUT ZOLLARIS

Zollaris Corporation is a 30,000 state-of-the-art facility located in Hawkesbury, ON. The facility was commissioned in 2019 and founded by experience pharmaceuticals leaders. Zollaris has several categories of licenses which enable it to contract manufacture, perform technical analysis of natural products (“NPNs”), cannabinoids and psychedelic’s for customers and its own brands to be sold in the appropriate medical and recreational channels.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by the use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include the Company’s inability to obtain sufficient financing to execute its business plan; competition; regulation; anticipated and unanticipated costs and delays; the success of the Company’s research and development strategies; the ability to obtain orphan drug status; the applicability of the discoveries made; the successful and timely completion and uncertainties related to the regulatory approval process; the timing of future clinical trials; the timing and outcomes of regulatory or intellectual property decisions; and other risks disclosed in the Company’s public disclosure record on file with the relevant regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release, and the Company does not undertake any obligation to publicly update them to reflect new information or subsequent events or otherwise except as required by applicable securities legislation.

Share article on social media or email:

JUPITER, Fla. (PRWEB)
February 16, 2022

An upcoming episode of Advancements with Ted Danson, scheduled to broadcast Q2/2022, will focus on recent developments in state-of-the-art healthcare technology.

This segment will explore how recent developments in healthcare technology are providing a more personalized approach to care. Delving into how technology plays a role, the show will explore Smartdocs, an easy-to-use healthcare platform that provides access to care based on patients’ needs.

Viewers will learn how Smartdocs creates innovative technology that delivers high quality, individualized care. Learn how the state-of-the-art application, built on medical science, ensures optimal care of patients around the globe.

“Smartdocs is an innovative, interactive disruptive technology using proven principles to change the landscape of healthcare for everyone in every area of the world. Our mission is to deliver quality healthcare based on science, despite patient location and their economic resources,” said LaDonna Carlisle (Carlyle) Founder & CEO.”

The segment will also explore how by providing patients with accurate, current, and concise information, Smartdocs helps to put the right information into patients & providers hands, when and where they need it.

“With step-by-step guidance of procedures, devices, and management at the point of care, the interactive technology places education in the palm of the patients & providers hands, so they can make better informed decisions about their health,” said Richard Simon, producer for the Advancements series.

About SmartDocs:

Creating Digital Health Solutions at Point of Care, Smartdocs develops and delivers innovative technology and high-quality individualized care to people throughout the world.

For more information, visit: http://www.smartdocsapp.com.

About Advancements and DMG Productions:

Advancements is an information-based educational television series targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call 866-496-40

Share article on social media or email:

Under Tony’s leadership, the Board of Directors is confident that our strategic direction, organizational growth and development, dedication to innovation, and delivery of impactful, client-valued safety services will continue to drive our future success.

NEWARK, Del. (PRWEB)
February 16, 2022

Driving Dynamics has recently announced a number of senior position promotions, with key leadership changes including the appointment of Tony Vinciguerra as President & CEO and Debbie Balestra transitioning to Chief Operating Officer (COO). Vinciguerra is stepping up from the COO role, following the recent retirement of managing owner Art Liggio, who will now serve as Chairman of the Board and remain active in the organization.

In announcing the changes, the Driving Dynamics board emphasized its gratitude for the many years of great leadership Art has provided. Inducted to the Fleet Hall of Fame in 2020, he guided the strategic vision and expertise which led the company to the success it enjoys today. The board expressed appreciation that Art will stay on as chairman, affording Driving Dynamics the continued benefit of his expertise, counsel, and partnership.

The shifts in leadership represent Driving Dynamics’ focus on driving growth and innovation in fleet safety management amid the ever-increasing safety challenges drivers and fleets face. Vinciguerra and Balestra will be responsible for the company’s strategic guidance and collaboration with key stakeholders to ensure the organization is positioned to continuously achieve its mission of improving overall fleet safety performance.

“Tony brings a unique set of skills, perspectives, and relationships to lead Driving Dynamics.” said Art Liggio, Driving Dynamics’ new Chairman of the Board. “Under his leadership, the Board of Directors is confident that our strategic direction, organizational growth and development, dedication to innovation, and delivery of impactful, client-valued safety services will continue to drive our future success.”

Vinciguerra joined the company in 2017 as its COO after the acquisition of Center for Transportation Safety (CTS). Since his involvement Driving Dynamics has tripled its revenue volume and expanded its service offerings. He’s been cited as being instrumental in providing strategic and financial oversight and advancing operational processes, systems, and product development. His prior experience includes more than 25 years with PHH and Element Fleet Services. Vinciguerra also held IT positions with Coopers & Lybrand and Westinghouse Corporation.

Balestra, with more than 30 years of experience managing risk, safety, and insurance programs, has worked for Driving Dynamics since 2010 and most recently served as the Vice President of Client Relations. Her extensive background includes account and database management, large account implementations, the integration of customer-facing technologies, and helping the organization implement management services for accounts with up to 10,000 drivers. Prior to joining Driving Dynamics, Balestra held positions at The CEI Group, TotalFinaElf and Aon.

Additionally, Driving Dynamics announced the promotions of Ben Langley and Tracy Caldwell.

Langley has been named Vice President of Training & Development stepping up from his position as Director of Training & Operations. In his new role he will oversee all training experiences including managing a national team of instructors and coaches and overseeing the development of the company’s courses. Langley joined Driving Dynamics in 2013 as a consultant and came onboard full time 2015. He brings more than 30 years of progressive safety leadership experience and extensive driver safety knowledge.

Caldwell has been promoted to Director of Partner Engagement & Account Management and will manage the Driving Dynamics’ strategic partnerships and help develop client relationships. Formerly as the Risk & Safety Consultant, she drove sales for the company’s technology-based services and managed its learning management system. Prior to joining Driving Dynamics in 2018, Caldwell worked for Element Fleet Corporation where she collaborated and consulted with clients to develop custom safety programs and institute industry standard best practices.

About Driving Dynamics Inc.

Driving Dynamics provides advanced performance driver safety training, coaching and fleet risk management services throughout North America. In business for more than 30 years, its behind the wheel, virtual, computer-based learning, in-person classroom and simulation training and driver risk programs are based on sound research, proven learning methodologies and expert instruction.

Headquartered in Newark, Delaware, it was named as Top-20 safety training company by Training Industry Inc for five consecutive years. The company offers a comprehensive range of services for fleet operators and drivers of passenger cars through commercial motor vehicles.

• 
  DriverAdvantage™ – Light to medium duty instructor-led training and coaching services
• DrivActiv™ Online – Technology-based driver training and risk solutions
• Center for Transportation Safety – A commercial motor vehicle training services partner

For more about Driving Dynamics visit: http://www.drivingdynamics.com

Share article on social media or email:

The landscape of the healthcare industry has inarguably evolved the last two years and being able to pivot where necessary in order to get our clients the best results possible has been our core priority.

ATLANTA (PRWEB)
February 16, 2022

ARPR, an award-winning tech PR agency at the epicenter of the future of PR, today announced the addition of two healthcare technology clients to its portfolio of global healthcare brands, which spans from patient engagement to cloud-based imaging software. With the addition of DeliverHealth and HHAeXchange, as well as existing client scope expansions, the healthIT practice group has already grown 25% YoY.

Recent client additions to the ARPR healthIT practice group include:

• HHAeXchange – Headquartered in New York, HHAeXchange is the leading technology platform for homecare and self-direction program management, developed specifically for Medicaid home and community-based services.
• DeliverHealth – Headquartered in Wisconsin, DeliverHealth simplifies Electronic Health Record, patient engagement and revenue cycle complexities, so providers can spend more time delivering the care patients need and less on documentation and technology.

These healthIT companies chose ARPR for its understanding of the technologies they’re built on, industry challenges they’re solving, the healthcare providers, clinicians and patients they serve, as well as the agency’s Panorama Approach, which seamlessly integrates traditional public relations, social media, content marketing and lead generation to drive measurable results.

To further support the practice’s client strategy and rapid growth, ARPR continues to invest in its team. Leading the practice group, Cortney Williams was recently promoted to HealthIT Practice Group Director, where she oversees strategy and team development across the agency’s healthcare technology client roster. In addition, Marti Cersovski was hired as Account Director in late 2021, bringing more than two decades of PR and project management experience to the role. Furthermore, Michelle Rand and Taylor Callis were both recently promoted to Account Manager roles, also supporting the healthcare team. Click here to view more open positions at ARPR.

“At ARPR, we strive to go above and beyond what clients expect from a ‘normal’ agency experience,” said Cortney Williams. “The landscape of the healthcare industry has inarguably evolved the last two years and being able to pivot where necessary in order to get our clients the best results possible has been our core priority. The healthcare IT industry is growing, and we’re proud to be growing right alongside it.”

Since 2012, ARPR has won 10 awards for its work on behalf of its health tech clients. Moreover, the leading tech PR firm has been named a two-time grand prize finalist in Ragan’s Health Care Agency of the Year contest. Click here to see how ARPR helped a healthIT company accelerate web traffic and improve domain authority by securing 50 media placements, 60% of which had backlinks – resulting in a 366% increase in web referrals and increased domain authority by seven points in just four months.

About ARPR

ARPR is an award-winning tech PR agency at the epicenter of the future of PR. Headquartered in Atlanta, ARPR helps its clients’ reputations thrive and their sales pipelines prosper through highly-integrated marketing strategies that push the limits of what a public relations firm can achieve. Since 2012, ARPR has twice been named Small Agency of the Year, dubbed a Best Place to Work six times, was honored as the 2016 Technology Agency of the Year and the 2018 Agency that Gets Results. For more information on ARPR clients and services, visit http://www.arpr.com and follow @AR_ _PR on Twitter and Instagram.

Share article on social media or email:

Joy A. Lewis, American Hospital Association executive, elected to CHC: Creating Healthier Communities’ National Board of Directors

“Together, we can work to promote the conditions where all individuals have a fair and just opportunity to reach their highest potential for health and overall well-being.”

ALEXANDRIA, Va. (PRWEB)
February 16, 2022

CHC: Creating Healthier Communities, a nationwide nonprofit that addresses the barriers to good health and equity, today announced that Joy A. Lewis was unanimously elected to its national board of directors.

“We’re honored to have Joy Lewis join the board,” said Thomas G. Bognanno, president and CEO at CHC. “Her significant expertise in health equity will help us accelerate our mission and continue to advance better health and wellbeing for all people.”

Joy A. Lewis, MSW, MPH, is senior vice president, health equity strategies and executive director, Institute for Diversity and Health Equity at the American Hospital Association (AHA). In her dual roles, Lewis has broad oversight for several key association priorities and functions related to diversity, health equity and inclusion to support and build healthy communities. She also serves as a member of the executive management team of the AHA.

Before joining the AHA, Lewis held several positions over almost two decades at Kaiser Permanente in CA.

“I’m proud to join CHC’s board,” said Joy A. Lewis, board director at CHC. “Together, we can work to promote the conditions where all individuals have a fair and just opportunity to reach their highest potential for health and overall well-being.”

Lewis sits on the board of directors for the Institute for Clinical and Economic Review (ICER) and serves on several committees including the AAMC’s Health Workforce Research Committee and Bristol Myers Squibb Foundation Expert Advisory Committee. Outside of work, she fuels her passion for the arts by serving as a board member of Round House Theatre located in Bethesda, MD. Joy holds a bachelor’s degree in psychology and sociology from Wesleyan University, and dual master’s degrees in social work from Howard University and public health from the University of California – Los Angeles.

About CHC: Creating Healthier Communities

CHC: Creating Healthier Communities brings nonprofits, businesses, and communities together around a shared commitment to better health and wellbeing. For more than 65 years, CHC has worked with partners to address the barriers to good health and equity and create resilient communities where everyone can thrive. CHC’s role is to advance equity, enhance the capacity of nonprofit organizations, connect and convene diverse stakeholders, and harness collective resources and programs to activate collaborations that address root causes, increase impact, and improve the health of our communities. Join us at chcimpact.org or @chcimpact.

Share article on social media or email:

IBM QRadar and Cynerio together give healthcare security teams the visibility and intelligence they need to find and block potential attacker pathways on connected devices.

NEW YORK (PRWEB)
February 16, 2022

Cynerio, a leading provider of healthcare IoT cybersecurity, today announced an integration with IBM Security QRadar SIEM. Cynerio’s integrations with IBM QRadar are designed to help to safely expedite risk management and security incident response in healthcare environments.

Patient care has seen incredible improvements due to the data, insight, and timeliness provided by connected medical devices. However, as the footprint of these devices in hospitals expands, so do the number of threats, vulnerabilities, and attacker pathways towards them. In the wake of the recent pandemic, healthcare has suffered a relentless onslaught of ransomware attacks and data breaches, with nearly a quarter of those attacks originating on a connected medical or IoT device. The inherent vulnerabilities of IoT devices, which often can’t be secured through traditional IT security tools, have made hospitals and healthcare facilities lucrative targets for increasingly sophisticated threat actors.

To help protect these medical and connected device environments, data from the Cynerio platform can now feed into IBM QRadar SIEM, bringing together IBM’s risk identification and security event monitoring with Cynerio’s medical-specific and contextual device data. This integration allows customers increased visibility into risks and attacks in their IoT and IoMT environments within QRadar’s “single pane of glass” that many organizations already leverage to respond to risk across their IT infrastructure.

“Hospital security professionals increasingly need solutions that will go beyond taking a simple inventory of all their connected devices and actually streamline the process for remediating the critical device risks that attackers are increasingly using as entry and pivot points,” said Daniel Brodie, CTO and co-founder at Cynerio. “IBM QRadar and Cynerio together give healthcare security teams the visibility and intelligence they need to find and block potential attacker pathways on connected devices.”

The new Cynerio-IBM QRadar integration is freely available to the security community through IBM Security App Exchange, a marketplace where developers across the industry can share applications based on IBM Security technologies. As threats are evolving faster than ever, collaborative development amongst the security community will help organizations adapt quickly and speed innovation in the fight against cybercrime.

For more information, please visit the IBM QRadar website at http://ibm.com/qradar or the Cynerio Website at http://www.cynerio.com/partners. A datasheet about the integration can be found here.

About Cynerio

Cynerio is the one-stop-shop Healthcare IoT security platform. With solutions that cater to healthcare’s every IoT need – from Enterprise IoT to OT and IoMT – we promote cross-organizational alignment and provide hospitals the control, foresight, and adaptability they require to stay cyber-secure in a constantly evolving threatscape. We empower healthcare organizations to stay compliant and proactively manage every connection on their own terms with real-time IoT attack detection & response and rapid risk reduction tools, so that they can focus on a hospital’s top priority: delivering quality patient care. For more information visit http://www.cynerio.com, or follow Cynerio on Facebook, Twitter, and LinkedIn. For more information about the integration email us at IBM@Cynerio.com.

Share article on social media or email: